Literature DB >> 500773

Inclusion of vindesine in sequential chemotherapy based upon the circadian rhythm of human solid tumors.

C Focan, S Le Hung, J J Claessens, H Debruyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 500773     DOI： 10.1007/bf00411116

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  4 in total

1.  [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].

Authors:  C Focan
Journal:  Nouv Presse Med       Date:  1975-11-08

2.  Circadian rhythm and chemotherapy for cancer.

Authors:  C Focan
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

3.  Sequential chemotherapy and circadian rhythm in human solid tumours. A randomised trial.

Authors:  C Focan
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors:  C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  4 in total
  1 in total

1.  Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors:  C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.